Uroprost-D (Prostate extract) 6 mg rectal suppositories 10 pieces
Description Uroprost-D:
Agent for treating chronic prostatitis
Composition
Prostate extract 30 mg, which corresponds to the content of water-soluble peptides 6 mg.
Auxiliary substances: dimethyl sulfoxide - 90 mg, macrogol 1500 (polyethylene oxide 1500) - 2180 mg.
Pharmacological effect Uroprost-D:
A medicinal agent of animal origin. It has an organotropic effect on the prostate gland. Reduces edema, leukocyte infiltration of the prostate, normalizes secretory function of epithelial cells, increases the number of lecithin grains in the secret of acinuses, stimulates muscle tone of the bladder. It reduces thrombosis, has antiaggregant activity, and inhibits the development of venal thrombosis in the prostate. Normalizes prostate and ejaculate parameters. Reduces pain and discomfort, eliminates disuric phenomena, improves copulative function.
Improves blood microcirculation in the bladder wall by dilating intact vessels (vasodilation effect), which helps restore oxygen delivery to tissues in hypoxia; This stimulates physiological repair. It has an anti-inflammatory effect by improving bladder wall trophic processes and stimulating regenerative processes. Activation of the organ blood flow promotes the improvement of the adaptive and contractile activity of the detrusor, increasing the capacity of the bladder. The reduction of the detrusor ischemia can be explained by a marked decrease in bladder hyperactivity, which continues after the end of the application of the preparation containing prostate extract.
Pharmacokinetics
As a peptide, it is broken down by cellular proteases into amino acids. It has no cumulative effect.
Testimony Uroprost-D:
- Chronic prostatitis,
- benign prostatic hyperplasia,
- pre- and post-operative prostatic conditions.
- Treatment of urgenic urinary incontinence,
- urgent calls to urinate and frequent urination with uncomplicated forms of bladder hyperactivity in women in the
- climacteric and postmenopausal periods.
Contraindications
Increased sensitivity to active matter, age up to eighteen years.
Use in pregnancy and breastfeeding
Not applicable in women
Method of use and doses Uroprost-D
Inside, rectal, in/m. The dose and frequency of use depends on the indications and the dosage form used.
Special Instructions Uroprost-D
Treatment of chronic prostatitis should be complex, involving the use of different groups of drugs and non-medicamental treatments. In treatment it is recommended to carry out an analysis of the prostate secret.
Terms of Sale
No prescription.
- Nosology (ICD codes)
- N40
- Prostate hyperplasia
